A transversal approach based on multidisciplinary team meetings model

  • Screening tools and AI
  • Genomic expression testing
  • IDC and pre-malignant lesion
  • Updated standards in HR+ non metastatic disease
  • HER2+ non metastatic management
  • Triple negative non metastatic
  • Breast cancer in elderly women